CD38 and systemic lupus erythematosus: Supporting these findings in the setting of SLE, PBMCs from SLE patients and age-, sex-, and ethnicity-matched healthy donors showed that CD38+ CD4+ T cells had significantly higher p4E-BP1 levels as compared to CD38− CD4+ T cells (Figure 4A).